Clinical Trial

A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy Subjects

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study is a randomized, parallel-group, open-label Phase I clinical trial designed to compare the bioavailability and safety of subcutaneous SHR-1819 injection administered via different injection devices in healthy subjects.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-24.
Status change: Not Yet Recruiting → Active, Not Recruiting 2026-04-24
Trial Details
NCT Number NCT07264335
Lead Sponsor Guangdong Hengrui Pharmaceutical Co., Ltd
Conditions Atopic Dermatitis
Enrollment 160 participants
Start Date 2026-03-07
Primary Completion 2026-04 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2026-04-29